SCHEMBL18106909

SCHEMBL18106909

Brc1cccc(C2CC2)c1.O=C(O)Nc1nc2ccccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.60
NPC1 O15118 8/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
SMN1; SMN2 Q16637 5/20 0.53
LPAR2 Q9HBW0 1/20 0.52
POLB P06746 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
CYP1A2 P05177 1/20 0.50
PKM P14618 1/20 0.49
MAOB P27338 1/20 0.49
ADORA2A P29274 1/20 0.49
LMNA P02545 2/20 0.48
CYP3A4 P08684 1/20 0.48
MTOR P42345 1/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18106906 0.88 SMN1; SMN2 (0.63) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL18106895 0.88 LPAR2 (0.67) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL18106896 0.87 NPC1 (0.60) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL18106903 0.83 IRAK4 (0.62) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL18106887 0.82 NPC1 (0.51) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL18106907 0.81 NPC1 (0.60) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL15944974 0.79 LPAR2 (0.77) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL204726 0.79 NPC1 (0.73) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL18106899 0.79 DEGS1 (0.40) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL18106898 0.77 LPAR2 (0.66) RAB9ANPC1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2742029-B1 N-(BENZIMIMDAZOL-2-YL)-CYCLOPROPANE CARBOXAMIDES AS LYSOPHOSPHATIDIC ACID ANTAGONISTS MERCK PATENT GMBH (DE) 2016-10-05 EP claimed